- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Hodgkin Lymphoma of Intestine
Total 7656 results
-
TakedaRecruitingRelapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)United States
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin LymphomaUnited States, Australia
-
SanofiCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin LymphomaUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
Novartis PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaSpain, Korea, Republic of, Israel, Japan, Germany, Singapore, Finland
-
ImmunityBio, Inc.Not yet recruitingNon Hodgkin's Lymphoma Refractory/RelapsedUnited States
-
Antengene Therapeutics LimitedTerminatedSolid Tumor, Non-Hodgkin's LymphomaChina, Taiwan
-
Adagene IncCompletedSolid Tumors, Non-Hodgkin LymphomaUnited States
-
SCRI Development Innovations, LLCInfinity Pharmaceuticals, Inc.CompletedStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesLymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | T-cell LymphomaUnited States
-
Robert LowskyNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Myeloproliferative Neoplasm | T-Cell Non-Hodgkin LymphomaUnited States
-
Luminary TherapeuticsCase Comprehensive Cancer CenterRecruitingLymphoma, Non-Hodgkin Lymphoma, B-CellUnited States
-
Haihe Biopharma Co., Ltd.RecruitingAdvanced Solid Tumor | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryUnited States, China
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Anaplastic Large Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent... and other conditionsUnited States
-
University of NebraskaBristol-Myers SquibbRecruitingFollicular Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma | Relapsed Non-Hodgkin Lymphoma | Mediastinal Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Guangzhou Excelmab Inc.RecruitingSafety and Efficacy of EX103 in Subjects With Relapsed/Refractory CD20-Positive Non-Hodgkin LymphomaCD20-positive Non-Hodgkin LymphomaChina
-
Conjupro Biotherapeutics, Inc.SuspendedCD20 Positive Non Hodgkin LymphomaUnited States
-
Adagene (Suzhou) LimitedTerminatedSolid Tumor | Non Hodgkin LymphomaChina
-
The Christie NHS Foundation TrustTerminatedCD19 Positive Non-Hodgkin LymphomaUnited Kingdom
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
Chongqing Precision Biotech Co., LtdPeking University Cancer Hospital & InstituteRecruitingB Cell Lymphoma | Non Hodgkin LymphomaChina
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)RecruitingRecurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Indolent Adult Non-Hodgkin...United States
-
Altor BioScienceTerminatedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Hodgkin Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | T-Cell Chronic Lymphocytic Leukemia | Recurrent Childhood Non-Hodgkin... and other conditionsUnited States, Germany
-
AmgenCompletedCancer | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Thrombocytopenia | Oncology | Chemotherapy-Induced Thrombocytopenia
-
Henan Cancer HospitalRecruitingNon-hodgkin Lymphoma,B CellChina
-
Anne Beaven, MDCTI BioPharmaCompletedNon-Hodgkin's LymphomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.TerminatedNon-Hodgkin's LymphomaUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
Duke UniversityGlaxoSmithKlineCompletedLymphoma, B-CellUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompleted
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Chinese PLA General HospitalPeking University; EdiGene Inc.RecruitingNon Hodgkin's LymphomaChina
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingNon-hodgkin's LymphomaChina
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Changchun GeneScience Pharmaceutical Co., Ltd.TerminatedSolid Tumor | Non-Hodgkin LymphomaChina
-
Adagene (Suzhou) LimitedCompletedSolid Tumor | Non-Hodgkin LymphomaChina
-
Stanford UniversityKite PharmaRecruitingNon-Hodgkin Lymphoma | Large B-cell LymphomaUnited States
-
Baylor College of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); The Methodist... and other collaboratorsRecruitingLymphoma | Non-Hodgkin's Lymphoma | Hodgkin's Disease | Lymphoproliferative DiseaseUnited States
-
Azienda Ospedaliera Città della Salute e della...CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma
-
Chinese PLA General HospitalRecruitingNon-hodgkin Lymphoma,B CellChina
-
Spectrum Pharmaceuticals, IncTerminated
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCTerminated
-
Ruijin HospitalUnknownNon-hodgkin Lymphoma,B CellChina
-
Timmune Biotech Inc.UnknownNon-hodgkin Lymphoma,B CellChina
-
Asan Medical CenterSchering-PloughCompletedNon-Hodgkin's LymphomaKorea, Republic of
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
The Cleveland ClinicCompletedLymphoma, B-CellUnited States
-
Chinese PLA General HospitalRecruiting